Carl June, MD, shares his scientific journey, from medical research officer in the U.S. Navy to leader behind the first FDA-approved gene therapy, during his one-on-one conversation with ASGCT President Hans-Peter Kiem, MD, PhD. Welcome to the third episode of Giants of Gene Therapy!
Dr. June is a professor in immunotherapy in the Department of Pathology and Laboratory Medicine at University of Pennsylvania's Perelman School of Medicine, the director of the Center for Cellular Immunotherapy, and the director of the Parker Institute for Cancer Immunotherapy at Penn. He was instrumental in bringing CAR T cells to the clinic and receiving the first FDA approval for CAR T cell therapy in 2017. 
Dr. June is a prolific researcher who has published more than 500 manuscripts. He's received numerous awards and honors and has been the founder or co-founder of many companies involved in T cell therapies. His discoveries launched a new era of cancer treatment options. Dr. June has been an ASGCT member and Annual Meeting keynote speaker.
Music by: Steven O'Brienhttps://www.steven-obrien.net/
"Making Progress"
(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.